Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Beyondspring Inc

BYSI ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$0.84

▼ -15.78%

Market Cap $34.50M · Vol 96.03K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$34.50M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

32.73

Momentum

Beta

0.06

vs Market

52W High

$2.40

65.04% below

52W Low

$0.74

13.24% above

Volume

96.03K

Avg 70.51K

P/B

N/A

Price-to-book

ROE

-321.46%

Return on equity

Free Float

85.73%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Beyondspring Inc (BYSI) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BYSI pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.28%

-36.91%

-42.92%

-33.93%

YTD

-48.52%

-58.25%

-18.53%

-96.13%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-8,715,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	-321.46%
ROA · ROIC	-28.63% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	41.12M

Technical Indicators

50-Day SMA	$1.38
200-Day SMA	$1.61
RSI (14)	32.73
Beta	0.06
52-Week High	$2.40
52-Week Low	$0.74

Volume Today	96.03K
Avg Daily Volume (30D)	70.51K
Relative Volume	1.36x
Volatility (10D)	201.10
Volatility (30D)	128.91
Free Float	85.73%

Analyst Consensus

N/A

Current Price $0.84

Mean Target N/A

52W Low$0.74 52W High$2.40

Current

Target

$0.74 $2.40

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00F9YLSV3

ISINKYG108301006

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

BeyondSpring Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to improve clinical outcomes for patients with high unmet medical needs. Its lead asset, Plinabulin, is in late-stage clinical development as an anti-cancer agent in non-small cell lung cancer (NSCLC) and a range of cancer indications. The Company’s mechanism of action as a dendritic cell maturation agent supports both anti-cancer activity and immune modulation, offering an approach to resensitizing tumors to checkpoint inhibitors. It also has a pipeline of immuno-oncology product candidates, BPI-002 program, which is based on an oral small molecule agent that increases T-cell co-stimulation; BPI-003 program, which is based on a small molecule inhibitor of IKK, a protein kinase, and BPI-004 program, which is focused on a small molecule that induces the production of neo-antigens by tumor cells, allowing tumors containing no immune cells to be infiltrated by the immune system.